Advisers to the US Food and Drug Administration agree that it’s important to have a Covid-19 vaccine for children, though there’s some disagreement over how potential vaccines are researched and authorized, FDA adviser Dr. Paul Offit said Thursday.
The FDA’s Vaccines and Related Biological Products Advisory Committee met Thursday to discuss what kind of information the FDA needs to consider ahead of authorizing a vaccine for children 12 and under.
“I'm confident that there was unanimity among the advisers that it's important to have a vaccine for children,” Offit told CNN’s Wolf Blitzer.
Offit noted that the advisers have differing views on issues like what kind of information should be considered among the different age groups under 12, and how many children should be included in trials.
“I certainly think we would have a vaccine by early next year, and hopefully we'll have a vaccine for the 6-to-12-year-old by the end of the year,” he said.
“If we're past the pandemic – if this is all behind us – then that's not going to be an issue, but we're not past the pandemic,” Offit added. “The variants are still out there and becoming more contagious. I think when the winter comes, you're going to see this virus surge again, so we still need a vaccine.”